TD Cowen on CVS Health (CVS): 'CNC's Pain Could Be CVS's Gain'
Tweet Send to a Friend
TD Cowen analyst Charles Rhyee reiterated a Buy rating and $95.00 price target on CVS Health (NYSE: CVS).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
